- Home
- / Tourmaline Bio
Tourmaline Bio
Stock Price
$27.1
2024-10-29
Market Capitalization
$694.9 M
2024-10-29
Tourmaline Bio Summary
Company Summary
- Overview
- Tourmaline Bio is a late-stage clinical biotechnology company that develops medicines for life-altering immune and inflammatory diseases.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- New York, NY, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
1 location detected
New York, NY HQ
United States
27 W 24th St #702
Tourmaline Bio Financials
Summary Financials
- Net income (Q2, 2025)
- ($23.1M)
- Cash (Q2, 2025)
- $31.4M
- EBIT (Q2, 2025)
- ($26.0M)
- Enterprise value
- $663.6M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026